FDA updates label for Sun Pharma’s UNLOXCYT, highlighting durable responses in advanced skin cancer
The update reflects long-term clinical trial data showing that many patients with mCSCC or laCSCC experienced lasting responses
The update reflects long-term clinical trial data showing that many patients with mCSCC or laCSCC experienced lasting responses
Call it a ray of hope for those enduring the pain of knee osteoarthritis -- the most common form of arthritis, affecting over 300 million people worldwide
The viewer aims to help radiologists work smarter, faster, and more collaboratively, while reducing IT complexity and freeing up valuable clinical time
It's a development that marks a major step forward for patients struggling with moderate-to-severe chronic spontaneous urticaria
The Signia Circular Stapler is the only circular stapler on the market with integrated leak testing and features designed to minimize risk
Itvisma is a one-time, fixed-dose therapy designed to tackle the genetic root cause of SMA
The deal accelerates GE HealthCare’s digital transformation, expanding its reach into outpatient care and enterprise imaging—a $2 billion-plus growth market
Solventum aims to accelerate innovation in acute wound care, expand its market reach, and deliver enhanced solutions for patients, clinicians, and shareholders
The deliveries bring the innovative medicine to communities heavily impacted by HIV just five months after U.S. FDA approval
Gobivaz is authorised for adults with rheumatoid arthritis (in combination with methotrexate), psoriatic arthritis (with or without methotrexate), axial spondyloarthritis, and ulcerative colitis
Subscribe To Our Newsletter & Stay Updated